RPL36AL

Across TCGA pan-cancer cohorts, RPL36AL Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RPL36AL data layer compared with 27 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RPL36AL Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RPL36AL expression acts as an unfavorable survival marker.

COAD and PRAD are the cancer types where RPL36AL Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.056	0.871	<.001	48	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RPL36AL–COAD (OS)

Open the COAD breakdown →